Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide for Uncontrolled PGTC Seizures in IGE
NCT02408523Phase 3Completed
- Sponsor
- UCB
- Start
- Apr 2015
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of lacosamide in idiopathic generalized epilepsy (IGE), sponsored by UCB. Started Apr 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
idiopathic generalized epilepsy (IGE)
Beyond the preview
Go deeper on NCT02408523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408523.